In a new Leadership Page published in JACC, ACC President Roxana Mehran, MD, FACC, and Eric J. Topol, MD, FACC, examine how AI, genomics, data science and other digital health technologies are transforming cardiovascular prevention. They describe a shift from traditional, population-based risk assessment to a more individualized, predictive and continuous approach to care, with the potential to identify cardiovascular risk long before symptoms develop. They also explore the promise and challenges of implementing emerging technologies responsibly and look ahead to the College's role in helping clinicians transition from reactive treatment to proactive prevention. “The cardiovascular community must embrace innovation while insisting on evidence, equity, transparency, and patient-centered implementation,” they write. Read more.